Review

Willow tirzepatide review

$4,788 a year, all in. That is $3,288 more than the cheapest option. Straightforward single-price plans.

Illustration of bottles and boxes lined up on a shelf

Recorded article date: 2026-09-18

This article retains historical comparison material. Its record date is not a current offer check. Selected newer reviews have their own dates and limits; consult those reviews and the applicable written terms before comparing a purchase.


One price, $399 a month, about $4,788 a year. Willow is the simplest listing in our table and among the dearest.

Simplicity is worth something in a market this cluttered — there is no membership to add, no tier to decode, no first-month rate that expires. The trouble is that the single number is roughly double what the cheapest programmes charge for the same class of medication.

The yearly bill

Historical comparison: saved figures with their record dates. Monthly figures may be equivalents; multiplying by twelve models an unchanged input, not a confirmed annual bill. Publisher-selected placement differs from numerical order.
Willow · tirzepatide
Advertised from$399/mo
Membership on topNone
What you actually pay$399/mo
Over twelve months$4,788
Versus the cheapest option+$3,288 a year
Cheapest-first position17 of 20

One published rate, no membership layer.

Where the money goes

There is less published detail here than at larger competitors on how dose changes are handled, how quickly you reach a clinician, and which pharmacy fills the prescription. Those are fair questions and the answers are not on the website.

Compounded GLP-1 provider with a single published monthly rate.

What the same money buys elsewhere

Coreage Rx month-to-month saves about $2,400 a year. Zealthy saves roughly $2,196. Even mid-priced Mochi, insurance team included, saves about $1,452.

Historical comparison: saved figures with their record dates. Monthly figures may be equivalents; multiplying by twelve models an unchanged input, not a confirmed annual bill. Publisher-selected placement differs from numerical order.
ProgrammeRecorded monthly figureRecorded figure × 12Difference from stored minimum × 12Record date
Coreage Rx Paid first placement
Recorded membership: $0
$199$2,388+$8882026-10-04
SuperHealthy Rx Publisher-selected placement
Recorded membership: $0
$135$1,620+$1202026-10-04
Likeness Rx Publisher-selected placement
Recorded membership: $0
$199$2,388+$8882026-10-04
Trimi
Recorded membership: $0
$125$1,500—2026-09-18
Ozari Health
Recorded membership: $0
$125$1,500—2026-09-18
Fifty 410
Recorded membership: $0
$133$1,596+$962026-09-18

Is the extra worth it?

Only if you value a single uncomplicated number above all else, and can absorb the difference.

What we checked

  • Compounded tirzepatide listed at $399/month.

Verified 2026-09-18. Prices in this market move, so treat anything older than a month as a starting point rather than a quote.

The good

  • A single price with no membership arithmetic.

The bad

  • At $399/month it is priced well above the flat-rate leaders.
  • Thinner published detail about clinical support than larger competitors.

Watch for this at checkout. There is little published detail on how dose changes are handled. Ask before committing.

Verdict

Clear pricing, high pricing, thin detail. Ask about dose changes and pharmacy sourcing before you commit.

Full workings for every programme are in the cheapest tirzepatide programmes, and our scoring is explained on how we rate.

Read next

CoreAge Rx pays us a commission on sign-ups through our links and pays for the first position in our price tables where included. How we rate · Disclosure